Literature DB >> 16380290

Challenges for control of taeniasis/cysticercosis in Indonesia.

Thomas Suroso1, Sri S Margono, Toni Wandra, Akira Ito.   

Abstract

Taeniasis/cysticercosis has been reported from several provinces of Indonesia: Papua (=former Irian Jaya), Bali, North Sumatra, East Nusa Tenggara, South East Sulawesi, Lampung, North Sulawesi, Jakarta, West Kalimantan, and East Java. The highest level of endemicity of taeniasis/cysticercosis has been found in Papua. Recent surveys in Jayawijaya District of Papua in 2000 and 2001 showed that 5 of 58 local people (8.6%) harbored the adult tapeworm, Taenia solium, whereas 44 of 96 people (45.8%), 50 of 71 pigs (70.4%), and 7 of 64 local dogs (10.9%) were seropositive for T. solium cysticercosis. Current surveys in Bali and Samosir District, North Sumatra during 2002-2005 revealed that Taenia saginata taeniasis has increased in incidence whereas T. solium cysticercosis is now rather rare compared to one-two decades ago in Bali. Taenia asiatica taeniasis is still common in Samosir District. Data from other provinces of Indonesia are very limited or unavailable. Control of these diseases is not a priority in the health or veterinary services, neither at central or local government levels. However, limited efforts toward control of the diseases have been implemented such as training of health personnel, community education on disease prevention, and provision of anthelminthics. A working group for control of the disease in Indonesia and an international collaboration have been established among Ministry of Health, Indonesia; University of Indonesia; and Asahikawa Medical College, Asahikawa, Japan since 1996. Future goals include implementation of active case finding (active surveillance) and treatment of tapeworm carriers, sustainable public health education, establishment of a system to check the quality of beef/pork and determine the distribution of infected animals and strengthening of laboratory capacity. Efforts to motivate provinces and districts should be implemented in developing the strategic plan to control of the disease. Given the considerable differences in cultures, religions, levels of education, socio-economic levels, daily habits and behaviour etc., control programmes must be adapted to the local situations.

Entities:  

Mesh:

Year:  2005        PMID: 16380290     DOI: 10.1016/j.parint.2005.11.025

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  5 in total

Review 1.  Taenia solium Taeniasis and Cysticercosis in Southeast Asia.

Authors:  Ar Kar Aung; Denis W Spelman
Journal:  Am J Trop Med Hyg       Date:  2016-02-01       Impact factor: 2.345

Review 2.  Epidemiology and genetic diversity of Taenia asiatica: a systematic review.

Authors:  Anita Ale; Bjorn Victor; Nicolas Praet; Sarah Gabriël; Niko Speybroeck; Pierre Dorny; Brecht Devleesschauwer
Journal:  Parasit Vectors       Date:  2014-01-22       Impact factor: 3.876

Review 3.  The present situation and towards the prevention and control of neurocysticercosis on the tropical island, Bali, Indonesia.

Authors:  Toni Wandra; Kadek Swastika; Nyoman S Dharmawan; Ivan Elisabeth Purba; I Made Sudarmaja; Takahiko Yoshida; Yasuhito Sako; Munehiro Okamoto; Ni Luh Putu Eka Diarthini; Dewa Ayu Agus Sri Laksemi; Tetsuya Yanagida; Minoru Nakao; Akira Ito
Journal:  Parasit Vectors       Date:  2015-03-07       Impact factor: 3.876

Review 4.  Epidemiology of Taenia saginata taeniosis/cysticercosis: a systematic review of the distribution in East, Southeast and South Asia.

Authors:  Ramon M Eichenberger; Lian F Thomas; Sarah Gabriël; Branco Bobić; Brecht Devleesschauwer; Lucy J Robertson; Anastasios Saratsis; Paul R Torgerson; Uffe C Braae; Veronique Dermauw; Pierre Dorny
Journal:  Parasit Vectors       Date:  2020-05-07       Impact factor: 3.876

5.  Brief historical remarks as an introduction for the international symposium on taeniasis/cysticercosis and echinococcosis.

Authors:  Akira Ito
Journal:  Parasitol Int       Date:  2005-12-07       Impact factor: 2.230

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.